Komori
Daito Pharmaceutical (4577) · FactAdvanced

Sales of New Health Food Products and Related Items

First written in FY2017-Q3. 15 of 29 entries say "Worsened", first in FY2018-Q1. Latest entry: FY2026.

29entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2023 – FY20252017: 320172018: 420182019: 320192020: 420202021: 320212022: 320222023: 420232024: 120242025: 220252026: 22026
Same theme, other companies
New health food and related product sales and sales recoveryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Sales of health foods and other products were ¥184 million, up 3.0% from the previous fiscal year.」

    Sales of health foods and other products, which had continued to decline due to intensified market competition, increased 3.0% from the previous fiscal year.
  2. FY2026-H1AdvancedAnnual report

    「Sales of health foods and other products were ¥100 million, up 7.2% year on year.」

    It reports that sales of health foods and other products, which had continued to decline due to intensified market competition, increased 7.2% year on year.
  3. FY2025WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥178 million, down 10.1% from the previous fiscal year.」

    Health foods and other products continued to face difficult conditions due to intensified market competition and other factors, with full-year sales down 10.1% from the previous fiscal year.
  4. FY2025-H1WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥93 million, down 16.4% year on year.」

    Health foods and other products continued to face difficult conditions due to intensified competition in the market and other factors, with sales down 16.4% year on year.
  5. FY2024WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥199 million, down 9.8% from the previous fiscal year.」

    Health foods and other products continued to face difficult conditions due to intensified market competition, with full-year sales down 9.8% from the previous fiscal year.
  6. FY2024-Q1WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥50 million, down 15.7% year on year.」

    Health foods and other products continued to face difficult conditions due to intensified market competition, resulting in a 15.7% year-on-year decline in sales.
  7. FY2023WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥220 million, down 20.9% from the previous fiscal year.」

    Health foods and other products continued to face difficult conditions due to intensified market competition, with full-year sales down 20.9% from the previous fiscal year.
  8. FY2023-Q3RestatedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥166 million, down 19.1% year on year.」

    Health foods and other products continued to face difficult conditions due to intensified market competition, with sales down 19.1% year on year.
  9. FY2023-Q2WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥121 million, down 19.9% year on year.」

    Health foods and other products continued to face difficult conditions due to intensified market competition, with sales down 19.9% year on year.
  10. FY2023-Q1WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥60 million, down 12.4% year on year.」

    Health foods and other products continued to face difficult conditions due to intensified market competition, resulting in a 12.4% year-on-year decline in sales.
  11. FY2022-Q3RestatedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥205.673 million.」

    It states that health foods and other products continue to face difficult conditions due to intensified market competition.
  12. FY2022-Q2WorsenedAnnual report

    「Health foods and other products remained in difficult conditions due to intensified competition in the market and other factors, with sales of ¥151.396 million.」

    It states that health foods and other products, previously considered to be performing steadily through the preceding quarter, returned to difficult conditions due to intensified market competition.
  13. FY2022-Q1RestatedAnnual report

    「Health food and other products performed steadily, with revenue of ¥68.743 million.」

    It continues to describe the steady performance of health foods and other products, which has improved from the difficult conditions caused by intensified competition through the previous year.
  14. FY2021-Q3AdvancedAnnual report

    「Health food and other products performed steadily, with revenue of ¥208.941 million, up 10.7% from the same period of the previous year.」

    Health food and other products continued to perform steadily, up 10.7% from the same period of the previous year.
  15. FY2021-Q2AdvancedAnnual report

    「Health food and other products performed steadily, with revenue of ¥154.320 million, up 11.3% from the same period of the previous year.」

    Health food and other products, which had been described through the previous full fiscal year as suffering declining revenue and difficult conditions due to intensifying market competition, performed steadily in the second quarter, with revenue up 11.3% from the same period of the previous year.
  16. FY2021-Q1Business conditions improvedAnnual report

    「Health food and other products performed steadily, with revenue of ¥61.185 million, up 3.2% from the same period of the previous year.」

    Health food and other products, which had been described through the previous full fiscal year as suffering declining revenue and difficult conditions due to intensifying market competition, performed steadily in the first quarter, up 3.2% from the same period of the previous year.
  17. FY2020WorsenedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors, with revenue of ¥250 million, down 16.9% from the previous fiscal year.」

    The difficult situation for health food and other products continued, with full-year revenue of ¥250 million, down 16.9% from the previous fiscal year.
  18. FY2020-Q3WorsenedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors, with revenue of ¥188.756 million, down 13.1% from the same period of the previous year.」

    The difficult situation for health food and other products continued due to intensifying market competition, with revenue down 13.1% from the same period of the previous year.
  19. FY2020-Q2WorsenedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors, with revenue of ¥138.692 million, down 9.5% from the same period of the previous year.」

    The difficult situation for health food and other products continued due to intensifying market competition, with revenue down 9.5% from the same period of the previous year.
  20. FY2020-Q1WorsenedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors, with revenue of ¥59.313 million, down 20.6% from the same period of the previous year.」

    The difficult situation for health food and other products continued due to intensifying market competition, with revenue down 20.6% from the same period of the previous year.
  21. FY2019-Q3RestatedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors.」

    The company continues to describe health food and other products as being in a difficult situation due to intensifying market competition, as it did in the previous quarter.
  22. FY2019-Q2WorsenedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors.」

    Health food and other products, which had been described as performing steadily in the previous quarter due to new product sales and other factors, returned to a difficult situation in the second quarter due to intensifying market competition and other factors.
  23. FY2019-Q1Business conditions improvedAnnual report

    「Health food and other products performed steadily, supported by sales of new products and other factors.」

    While the previous full fiscal year described declining revenue and difficult conditions due to intensifying market competition, the first quarter described performance as steady, supported by sales of new products and other factors.
  24. FY2018WorsenedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors, with revenue of ¥320 million, down 8.1% from the previous fiscal year.」

    The difficult situation for health food and other products continued for the full fiscal year, with revenue of ¥320 million, down 8.1% from the previous fiscal year.
  25. FY2018-Q3RestatedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors.」

    The difficult situation for health food and other products due to intensifying market competition has been reiterated.
  26. FY2018-Q2RestatedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors.」

    The difficult situation for health food and other products due to intensifying market competition has been reiterated.
  27. FY2018-Q1WorsenedAnnual report

    「Health food and other products remained in a difficult situation due to intensifying competition in the market and other factors.」

    Health food and other products, which had been described as performing steadily in the previous period on the back of new product sales, entered a difficult situation due to intensifying market competition and other factors.
  28. FY2017AdvancedAnnual report

    「Health food and other products performed steadily, supported by sales of new products and other factors, with revenue of ¥348 million, up 2.1% year on year.」

    Health food and other products generated revenue of ¥348 million, up 2.1% year on year, supported by sales of new products.
  29. FY2017-Q3First statedAnnual report

    「Health food and other products performed steadily, supported by sales of new products and other factors.」

    The company states that health food and other products performed steadily, supported by sales of new products.
Moved together

"Reduction in the interest-bearing debt ratio and strengthening of equity capital" moved the same way as this thread, in the same document, in 12 of its 29 moves.

12107775★123456
  1. ★This thread
  2. 1Reduction in the interest-bearing debt ratio and strengthening of equity capital12×
  3. 2Risks Related to Interest-Bearing Debt, Interest Rates and Financial Covenants10×
  4. 3Risks from Drug Price Revisions and Healthcare Insurance System Reform7×
  5. 4Risk of Fluctuations in Raw Material and Purchase Prices7×
  6. 5Customer Credit Risk7×
  7. 6Expected Expansion of the Generic Drug Market5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Sales of New Health Food Products and Related Items | Daito Pharmaceutical Co.,Ltd. (4577) | Komori